Copyright © 2003 by the European Society of Cardiology.
The EuroHeart Failure survey programmea survey on the quality of care among patients with heart failure in Europe
Part 1: patient characteristics and diagnosis
a Department of Cardiology, University of Hull, Castle Hill Hospital, Castle Road, Kingston upon Hull HU16 5JQ, UK;b Göteborg, Sweden;c Zurich, Switzerland;d Paris, France;e Clichy, France;f Valencia, Spain;g Berlin, Germany;h Bergamo, Italy;i Birmingham, UK;j Warsaw, Poland;k Lisbon, Portugal;l Moscow, Russia;m Budapest, Hungary;n Groningen, The Netherlands;o Prague, Czech Republic;p Department of Primary Care & General Practice, University of Birmingham, UK;q Newcastle, UK
Received November 8, 2002;
accepted November 20, 2002
* Corresponding author. Tel.: +44-1482-624084; fax: +44-1482-624085
E-mail address: j.g.cleland{at}hull.ac.uk
Background The European Society of Cardiology (ESC) has published guidelines for the investigation of patients with suspected heart failure and, if the diagnosis is proven, their subsequent management. Hospitalisation provides a key point of care at which time diagnosis and treatment may be refined to improve outcome for a group of patients with a high morbidity and mortality. However, little international data exists to describe the features and management of such patients. Accordingly, the EuroHeart Failure survey was conducted to ascertain if appropriate tests were being performed with which to confirm or refute a diagnosis of heart failure and how this influenced subsequent management.
Methods The survey screened consecutive deaths and discharges during 20002001 predominantly from medical wards over a 6-week period in 115 hospitals from 24 countries belonging to the ESC, to identify patients with known or suspected heart failure.
Results A total of 46,788 deaths and discharges were screened from which 11,327 (24%) patients were enrolled with suspected or confirmed heart failure. Forty-seven percent of those enrolled were women. Fifty-one percent of women and 30% of men were aged >75 years. Eighty-three percent of patients had a diagnosis of heart failure made on or prior to the index admission. Heart failure was the principal reason for admission in 40%. The great majority of patients (>90%) had had an ECG, chest X-ray, haemoglobin and electrolytes measured as recommended in ESC guidelines, but only 66% had ever had an echocardiogram. Left ventricular ejection fraction had been measured in 57% of men and 41% of women, usually by echocardiography (84%) and was <40% in 51% of men but only in 28% of women. Forty-five percent of women and 22% of men were reported to have normal left ventricular systolic function by qualitative echocardiographic assessment. A substantial proportion of patients had alternative explanations for heart failure other than left ventricular systolic or diastolic dysfunction, including valve disease. Within 12 weeks of discharge, 24% of patients had been readmitted. A total of 1408 of 10,434 (13.5%) patients died between admission and 12 weeks follow-up.
Conclusions Known or suspected heart failure comprises a large proportion of admissions to medical wards and such patients are at high risk of early readmission and death. Many of the basic investigations recommended by the ESC were usually carried out, although it is not clear whether this was by design or part of a general routine for all patients being admitted regardless of diagnosis. The investigation most specific for patients with suspected heart failure (echocardiography) was performed less frequently, suggesting that the diagnosis of heart failure is still relatively neglected. Most men but a minority of women who underwent investigation of cardiac function had evidence of moderate or severe left ventricular dysfunction, the main target of current advances in the treatment of heart failure. Considerable diagnostic uncertainty remains for many patients with suspected heart failure, even after echocardiography, which must be resolved in order to target existing and new therapies and services effectively.
Key Words: Heart failure Survey Diagnosis Mortality Re-admission
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Torabi, J. G.F. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby, and K. Goode The timing of development and subsequent clinical course of heart failure after a myocardial infarction Eur. Heart J., April 1, 2008; 29(7): 859 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Pang, J. G.F. Cleland, J. R. Teerlink, S. P. Collins, C. J. Lindsell, G. Sopko, W. F. Peacock, G. C. Fonarow, A. Z. Aldeen, J. D. Kirk, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur. Heart J., March 2, 2008; 29(6): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Lenzen, A Rosengren, W J M S. op Reimer, F Follath, E Boersma, M L Simoons, J G F Cleland, and M Komajda Management of patients with heart failure in clinical practice: differences between men and women Heart, March 1, 2008; 94(3): e10 - e10. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition Eur. Heart J., February 1, 2008; 29(3): 413 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
E D Nicol, B Fittall, M Roughton, J G F Cleland, H Dargie, and M R Cowie NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland Heart, February 1, 2008; 94(2): 172 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Leclercq Upgrading from right ventricular pacing to biventricular pacing in pacemaker patients with chronic heart failure Heart, January 1, 2008; 94(1): 102 - 107. [Full Text] [PDF] |
||||
![]() |
W. J. Paulus, C. Tschope, J. E. Sanderson, C. Rusconi, F. A. Flachskampf, F. E. Rademakers, P. Marino, O. A. Smiseth, G. De Keulenaer, A. F. Leite-Moreira, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur. Heart J., October 2, 2007; 28(20): 2539 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swedberg Pure heart rate reduction: further perspectives in heart failure Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F20 - F24. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Breidthardt, M. Christ, M. Matti, D. Schrafl, K. Laule, M. Noveanu, T. Boldanova, T. Klima, W. Hochholzer, A. P Perruchoud, et al. QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure Heart, September 1, 2007; 93(9): 1093 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vollmann, H. Nagele, P. Schauerte, U. Wiegand, C. Butter, G. Zanotto, A. Quesada, A. Guthmann, M. R.S. Hill, B. Lamp, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure Eur. Heart J., August 1, 2007; 28(15): 1835 - 1840. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller, K. A. Hartman, M. F. Burritt, D. E. Grill, R. J. Rodeheffer, J. C. Burnett Jr, and A. S. Jaffe Serial Biomarker Measurements in Ambulatory Patients With Chronic Heart Failure: The Importance of Change Over Time Circulation, July 17, 2007; 116(3): 249 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Komajda, O. Hanon, M. Hochadel, F. Follath, K. Swedberg, A. Gitt, and J. G.F. Cleland Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I Eur. Heart J., June 1, 2007; 28(11): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, E. Donal, J. F. Aupetit, M. C. Aumont, M. Galinier, J. C. Eicher, et al. Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1733 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Konstam, M. Gheorghiade, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial JAMA, March 28, 2007; 297(12): 1319 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials JAMA, March 28, 2007; 297(12): 1332 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Elkayam, P. Hatamizadeh, and M. Janmohamed The Challenge of Correcting Volume Overload in Hospitalized Patients With Decompensated Heart Failure J. Am. Coll. Cardiol., February 13, 2007; 49(6): 684 - 686. [Full Text] [PDF] |
||||
![]() |
M. Schaufelberger and A. Rosengren Heart failure in different occupational classes in Sweden Eur. Heart J., January 2, 2007; 28(2): 212 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Siirila-Waris, J. Lassus, J. Melin, K. Peuhkurinen, M. S. Nieminen, V.-P. Harjola, and for the FINN-AKVA study group Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure Eur. Heart J., December 2, 2006; 27(24): 3011 - 3017. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, V.-P. Harjola, M. Hochadel, M. Komajda, J. Lassus, J. L. Lopez-Sendon, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur. Heart J., November 2, 2006; 27(22): 2725 - 2736. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Eurlings, J. L. Januzzi, and Y. M. Pinto Is acute heart failure a highly prevalent orphan disease? Eur. Heart J., November 2, 2006; 27(22): 2619 - 2620. [Full Text] [PDF] |
||||
![]() |
M. S. Nieminen Key issues of European Society of Cardiology guidelines on acute heart failure Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E6 - E11. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tavazzi, A. P. Maggioni, D. Lucci, G. Cacciatore, G. Ansalone, F. Oliva, M. Porcu, and on behalf of the Italian survey on Acute Heart Fai Nationwide survey on acute heart failure in cardiology ward services in Italy Eur. Heart J., May 2, 2006; 27(10): 1207 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Cowie, M. Komajda, T. Murray-Thomas, J. Underwood, B. Ticho, and on behalf of the POSH Investigators Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) Eur. Heart J., May 2, 2006; 27(10): 1216 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Purek, K Laule-Kilian, A Christ, T Klima, M E Pfisterer, A P Perruchoud, and C Mueller Coronary artery disease and outcome in acute congestive heart failure Heart, May 1, 2006; 92(5): 598 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
P A Mehta and M R Cowie Gender and heart failure: a population perspective Heart, May 1, 2006; 92(suppl_3): iii14 - iii18. [Full Text] [PDF] |
||||
![]() |
A. K. Chung, S. R. Das, D. Leonard, R. M. Peshock, F. Kazi, S. M. Abdullah, R. M. Canham, B. D. Levine, and M. H. Drazner Women Have Higher Left Ventricular Ejection Fractions Than Men Independent of Differences in Left Ventricular Volume: The Dallas Heart Study Circulation, March 28, 2006; 113(12): 1597 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur. Heart J., February 1, 2006; 27(3): 323 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Anwaruddin, D. M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J. L. Januzzi Jr Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study J. Am. Coll. Cardiol., January 3, 2006; 47(1): 91 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Daubert, C. Leclercq, and P. Mabo There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2204 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. L. Pina, M. A. Konstam, B. M. Massie, E. Roland, S. Targum, S. P. Collins, et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research Circulation, December 20, 2005; 112(25): 3958 - 3968. [Full Text] [PDF] |
||||
![]() |
S. Anwaruddin, D. M. Lloyd-Jones, A. Baggish, A. Chen, D. Krauser, R. Tung, C. Chae, and J. L. Januzzi Jr Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement: Results From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study J. Am. Coll. Cardiol., December 13, 2005; (2005) j.jacc.2005.08.051v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lenzen, E. Boersma, W. J.M. Scholte op Reimer, A. H.M.M. Balk, M. Komajda, K. Swedberg, F. Follath, M. Jimenez-Navarro, M. L. Simoons, and J. G.F. Cleland Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure Eur. Heart J., December 2, 2005; 26(24): 2706 - 2713. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Squire Managing patients with heart failure: the reality of clinical practice Eur. Heart J., December 2, 2005; 26(24): 2611 - 2613. [Full Text] [PDF] |
||||
![]() |
J D Newton, H M Blackledge, and I B Squire Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study Heart, December 1, 2005; 91(12): 1545 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K.A. Witte, N. P. Nikitin, A. C. Parker, S. von Haehling, H.-D. Volk, S. D. Anker, A. L. Clark, and J. G.F. Cleland The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure Eur. Heart J., November 1, 2005; 26(21): 2238 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tendera Epidemiology, treatment, and guidelines for the treatment of heart failure in Europe Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J5 - J9. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J.V. McMurray The role of angiotensin II receptor blockers in the management of heart failure Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J10 - J14. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Maggioni Review of the new ESC guidelines for the pharmacological management of chronic heart failure Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J15 - J20. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swedberg and I. Ekman Integrating heart failure guidelines into clinical practice Eur. Heart J. Suppl., October 1, 2005; 7(suppl_J): J21 - J25. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yoshida, K. Yamamoto, T. Mano, Y. Sakata, M. Nishio, T. Ohtani, M. Hori, T. Miwa, and T. Masuyama Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats Cardiovasc Res, October 1, 2005; 68(1): 118 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. de Silva, N. P. Nikitin, S. Bhandari, A. Nicholson, A. L. Clark, and J. G.F. Cleland Atherosclerotic renovascular disease in chronic heart failure: should we intervene? Eur. Heart J., August 2, 2005; 26(16): 1596 - 1605. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swedberg, L. G. Olsson, A. Charlesworth, J. Cleland, P. Hanrath, M. Komajda, M. Metra, C. Torp-Pedersen, and P. Poole-Wilson Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET Eur. Heart J., July 1, 2005; 26(13): 1303 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140. [Full Text] [PDF] |
||||
![]() |
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina Eur. Heart J., May 2, 2005; 26(10): 996 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade and F. Zannad Modern management of acute heart failure syndromes Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B3 - B7. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zannad Acute heart failure syndromes: the 'Cinderella' of heart failure research Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B8 - B12. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gheorghiade and G. Filippatos Reassessing treatment of acute heart failure syndromes: the ADHERE Registry Eur. Heart J. Suppl., April 1, 2005; 7(suppl_B): B13 - B19. [Abstract] [Full Text] [PDF] |
||||
![]() |
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology Eur. Heart J., February 2, 2005; 26(4): 384 - 416. [Full Text] [PDF] |
||||
![]() |
F. Gustafsson and J. M. O. Arnold COACHes, players, and heart failure teams: reply Eur. Heart J., February 1, 2005; 26(3): 314 - 315. [Full Text] [PDF] |
||||
![]() |
F. Gustafsson, C. Torp-Pedersen, M. Seibaek, H. Burchardt, L. Kober, and for the DIAMOND study group Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure Eur. Heart J., October 1, 2004; 25(19): 1711 - 1717. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bundkirchen and R. H.G Schwinger Epidemiology and economic burden of chronic heart failure Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D57 - D60. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dickstein Appearances can deceive: even brave hearts can fail Eur. Heart J., July 2, 2004; 25(14): 1181 - 1182. [Full Text] [PDF] |
||||
![]() |
M.J Lenzen, W.J.M Scholte op Reimer, E Boersma, P.J.M.J Vantrimpont, F Follath, K Swedberg, J Cleland, and M Komajda Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey Eur. Heart J., July 2, 2004; 25(14): 1214 - 1220. [Abstract] [Full Text] [PDF] |
||||






